Filing Details

Accession Number:
0001225208-13-002635
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-01 07:45:24
Reporting Period:
2013-01-30
Filing Date:
2013-02-01
Accepted Time:
2013-02-01 07:45:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1551792 D John Young Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Business Unit President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-01-30 26,752 $27.65 36,708 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 296 Indirect By Rule 16b-3 Plan
Common Stock 1,244 Indirect By Trustee under the Pfizer Share Ownership Plan